GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stereotaxis Inc (AMEX:STXS) » Definitions » Cyclically Adjusted PB Ratio

Stereotaxis (Stereotaxis) Cyclically Adjusted PB Ratio : (As of Apr. 27, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Stereotaxis Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Stereotaxis Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Stereotaxis's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stereotaxis Cyclically Adjusted PB Ratio Chart

Stereotaxis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Stereotaxis Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Stereotaxis's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Stereotaxis's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stereotaxis's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stereotaxis's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Stereotaxis's Cyclically Adjusted PB Ratio falls into.



Stereotaxis Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Stereotaxis's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Stereotaxis's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.202/129.4194*129.4194
=0.202

Current CPI (Dec. 2023) = 129.4194.

Stereotaxis Quarterly Data

Book Value per Share CPI Adj_Book
201403 -0.803 99.695 -1.042
201406 -0.727 100.560 -0.936
201409 -0.675 100.428 -0.870
201412 -0.613 99.070 -0.801
201503 -0.707 99.621 -0.918
201506 -0.754 100.684 -0.969
201509 -0.780 100.392 -1.006
201512 -0.818 99.792 -1.061
201603 -0.903 100.470 -1.163
201606 -0.992 101.688 -1.263
201609 -1.261 101.861 -1.602
201612 -0.974 101.863 -1.237
201703 -0.890 102.862 -1.120
201706 -0.887 103.349 -1.111
201709 -1.061 104.136 -1.319
201712 -1.165 104.011 -1.450
201803 0.039 105.290 0.048
201806 0.029 106.317 0.035
201809 0.030 106.507 0.036
201812 0.022 105.998 0.027
201903 -0.011 107.251 -0.013
201906 -0.022 108.070 -0.026
201909 0.342 108.329 0.409
201912 0.332 108.420 0.396
202003 0.312 108.902 0.371
202006 0.489 108.767 0.582
202009 0.475 109.815 0.560
202012 0.470 109.897 0.553
202103 0.469 111.754 0.543
202106 0.490 114.631 0.553
202109 0.464 115.734 0.519
202112 0.453 117.630 0.498
202203 0.433 121.301 0.462
202206 0.401 125.017 0.415
202209 0.371 125.227 0.383
202212 0.352 125.222 0.364
202303 0.316 127.348 0.321
202306 0.265 128.729 0.266
202309 0.231 129.860 0.230
202312 0.202 129.419 0.202

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Stereotaxis  (AMEX:STXS) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Stereotaxis Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Stereotaxis's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Stereotaxis (Stereotaxis) Business Description

Traded in Other Exchanges
Address
710 North Tucker Boulevard, Suite 110, St. Louis, MO, USA, 63101
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.
Executives
Paul J Isaac 10 percent owner 530 FIFTH AVENUE, 20TH FLOOR, NEW YORK NY 10036
Myriam Curet director 1020 KIFER ROAD, SUNNYVALE CA 94086
David Benfer director 5 SELDEN AVENUE, BRANFORD CT 06404
Kimberly R. Peery officer: Chief Financial Officer C/O STEREOTAXIS, INC., 4320 FOREST PARK AVENUE: SUITE 100, ST. LOUIS MO 63108
Kevin M. Barry officer: Chief Legal Officer & Secretar 4320 FOREST PARK AVENUE, 100, ST. LOUIS MO 63108
Ross B Levin director 530 FIFTH AVENUE, 20TH FLOOR, NEW YORK NY 10036
Fariba Fischel Ghodsian 10 percent owner 10990 WILSHIRE BOULEVARD, SUITE 1400, LOS ANGELES CA 90024
Dafna Capital Management Llc 10 percent owner 10990 WILSHIRE BOULEVARD, SUITE 1400, LOS ANGELES CA 90024
David Leo Fischel director 10990 WILSHIRE BOULEVARD, SUITE 1400, LOS ANGELES CA 90024
Arun Swarup Menawat director 2412 EIGHTH LINE, OAKVILLE A6 L6H6S9
Joe E Kiani director 4320 FOREST PARK AVENUE, SUITE 100, ST. LOUIS MO 63108
Paul Brathwaite officer: VP Research & Development C/O STEREOTAXIS, INC., 4320 FOREST PARK AVENUE, SUITE 100, ST. LOUIS MO 63108
Martin C Stammer officer: Chief Financial Officer C/O STEREOTAXIS, INC., 4320 FOREST PARK AVENUE, SUITE 100, ST. LOUIS MO 63108
Nathan Fischel director 10990 WILSHIRE BOULEVARD, SUITE 1400, LOS ANGELES CA 90024
Duane Desisto director C/O INSULET CORPORATION, 9 OAK PARK DRIVE, BEDFORD MA 01730